tirzepatide surmount-1 trial weight loss non-diabetic obesity without diabetes non- diabetic once weekly for the treatment of in people with type 2 (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 SURMOUNT-1: Tirzepatide Drastically GLP-1-based combination strategies for weight

GLP-1 drugs, also known as GLP-1 agonists, stimulate the pancreas to release insulin and suppress glucagon, another hormone that raises blood sugar

Participants on the higher dose also achieved trimmer waistlines and lower blood pressure, blood sugar and cholesterol, results showed

The ultimate picture will depend on long-term outcomes, side effect profile, and its effectiveness in various populations

Eating frequent small meals can alleviate nausea or heartburn, allowing the body to digest food more efficiently

While GLP-1 medications like compounded semaglutide (Ozempic and Wegovy) 1 and compounded tirzepatide (Zepbound and Mounjaro) assist in weight loss by reducing appetite and improving blood sugar regulation, your body isnt immune to the natural physiological processes that come with weight loss